DIAMIR BIOSCIENCES CORP. Contracts & Agreements
17 Contracts & Agreements
- Business Finance (7 contracts)
- Human Resources (5)
- Uncategorized (5)
- Underwriting Agreement (Filed With SEC on June 28, 2024)
- Share Exchange Agreement, dated October 1, 2014 (Filed With SEC on June 28, 2024)
- Amended and Restated Future Advance Promissory Note, issued to Kira Sheinerman, as of October 10, 2023 (Filed With SEC on June 28, 2024)
- Future Advance Promissory Note, issued to Samuil Umansky, as of March 15, 2023 (Filed With SEC on June 28, 2024)
- Form of Employment Agreement, by and between DiamiR Biosciences Corp and Alidad Mireskandari (Filed With SEC on June 28, 2024)
- Form of Consulting Agreement, by and between DiamiR Biosciences Corp and Fred Knechtel, dated August 22, 2022 (Filed With SEC on June 28, 2024)
- Amendment to Consulting Agreement dated August 31, 2023 (Filed With SEC on June 28, 2024)
- Small Business Innovation Research Program grant dated August 18, 2020 (Filed With SEC on June 28, 2024)
- Department of Health and Human Services grant dated April 27, 2021 (Filed With SEC on June 28, 2024)
- Department of Health and Human Services grant dated April 6, 2022 (Filed With SEC on June 28, 2024)
- Department of Health and Human Services grant dated December 4, 2020 (Filed With SEC on June 28, 2024)
- National Institute of Health grant dated August 12, 2021 (Filed With SEC on June 28, 2024)
- Insider Stock Purchase Agreement dated March 30, 2023 (Filed With SEC on June 28, 2024)
- 2014 Stock Option Plan, adopted on October 1, 2014 (Filed With SEC on June 28, 2024)
- 2024 Stock Option Plan, adopted on May 31, 2024 (Filed With SEC on June 28, 2024)
- Form of Employment Agreement, by and between DiamiR Biosciences Corp and Alidad Mireskandari dated as of June 20, 2024 (Filed With SEC on June 28, 2024)
- Form of Employment Agreement, by and between DiamiR Biosciences Corp and Gary Anthony dated as of June 20, 2024 (Filed With SEC on June 28, 2024)
